Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
Status:
Terminated
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effect of simvastatin and zoledronic acid on
M-protein and/or free light chains when added to conventional chemotherapy for the treatment
of multiple myeloma patients.
Phase:
N/A
Details
Lead Sponsor:
James Graham Brown Cancer Center University of Louisville
Collaborators:
James Graham Brown Cancer Center University of Louisville